PMID: 8448501Jan 1, 1993Paper

Methadone dose and heroin use during maintenance treatment

Addiction
J R CaplehornV J Gebski

Abstract

A retrospective study examined the association between methadone dose and in-treatment heroin use as measured by fixed-interval urine testing in a cohort of 62 patients admitted to an Australian maintenance program. Urinalysis and methadone dose data were collected on subjects for a maximum two years and were analysed using Zeger & Liang's (1986) method for modelling longitudinal data. While allowing for patient descriptors and the time period in which urine samples were collected, the relative odds of using heroin were reduced by 2% for every 1 mg increase in the maintenance dose of methadone. It is estimated that the odds of patients maintained on 40 mg of methadone using heroin were 2.2 times those of patients maintained on 80 mg.

References

Sep 1, 1977·The International Journal of the Addictions·A GoldsteinR W Hansteen
Mar 1, 1978·Archives of General Psychiatry·R J Harford, H D Kleber
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·J BoyagesV J Gebski
May 27, 1992·JAMA : the Journal of the American Medical Association·R E JohnsonP J Fudala
Sep 22, 1989·JAMA : the Journal of the American Medical Association·V P Dole
Feb 14, 1987·British Medical Journal·A R Moss
Sep 1, 1988·Journal of Health and Social Behavior·J C BallS R Friedman
Mar 18, 1985·The Medical Journal of Australia·J H LewisB M Learoyd
Oct 1, 1966·Archives of Internal Medicine·V P DoleM J Kreek
Feb 1, 1973·Archives of General Psychiatry·W R MartinR W Carpenter
Sep 1, 1970·The International Journal of the Addictions·J H Jaffe
Sep 1, 1981·Archives of General Psychiatry·W H McGlothlin, M D Anglin
Jan 1, 1981·The American Journal of Drug and Alcohol Abuse·B Kaul, B Davidow
Feb 1, 1980·Archives of General Psychiatry·W LingW E Carter
Jan 1, 1993·The International Journal of the Addictions·J R CaplehornD G Kleinbaum

❮ Previous
Next ❯

Citations

Jan 1, 1995·European Archives of Psychiatry and Clinical Neuroscience·G Bertschy
Nov 1, 1993·Journal of Substance Abuse Treatment·J R CaplehornA Wodak
Oct 6, 2005·Advances in Neonatal Care : Official Journal of the National Association of Neonatal Nurses·Shabnam LainwalaJames I Hagadorn
Mar 17, 2004·Social Science & Medicine·Margaret S Kelley, Dale D Chitwood
Jul 4, 2002·Drug and Alcohol Dependence·Kenzie L PrestonDavid H Epstein
Feb 26, 1998·Drug and Alcohol Dependence·D BestJ Strang
Aug 26, 1999·Drug and Alcohol Dependence·A Domingo-SalvanyJ Alonso
Aug 23, 2001·Journal of Substance Abuse Treatment·E RoblesD E McMillan
Apr 9, 1999·Journal of Substance Abuse Treatment·T Blaney, R J Craig
Jan 1, 1994·Drug and Alcohol Review·J WardW Hall
Jan 1, 1995·Drug and Alcohol Review·K HowardM J Christie
Dec 4, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Silvana De Castro, Eduardo Sabaté
Nov 17, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David A FiellinMarc N Gourevitch
Apr 5, 2002·The Journal of Perinatal & Neonatal Nursing·P WilbourneL B Curet
Nov 1, 1994·Addiction·A Johns
Mar 1, 2000·The Western Journal of Medicine·I B Anderson, T E Kearney
May 11, 2004·Journal of Addictive Diseases·W M WechsbergH Diesenhaus
Mar 24, 2005·Journal of Addictive Diseases·Randy BrownMichael Fleming
Sep 28, 2005·Journal of Addictive Diseases·Thomas M BradyPing Yu
Jan 1, 1995·American Journal of Public Health·D M HartelG H Friedland
Oct 22, 1998·Substance Use & Misuse·S MaguraS Demsky
Sep 1, 1994·The International Journal of the Addictions·J R Caplehorn
Oct 17, 1998·Psychological Reports·J B Murray
Jul 21, 2012·Asian Journal of Psychiatry·Biju ViswanathPratima Murthy
Mar 1, 2013·The Journal of Sexual Medicine·Nik Ruzyanei Nik JaafarHatta Sidi
Oct 17, 2015·Harm Reduction Journal·Tran Vu HoangStephen Mills
Sep 21, 2004·Human Psychopharmacology·John M CorkeryAdenekan Oyefeso
Feb 15, 2005·Australian and New Zealand Journal of Public Health·Richard HallinanGregory J Dore
Dec 5, 2014·Substance Abuse Treatment, Prevention, and Policy·Marcus BaumeisterSylvie A Petitjean
Sep 26, 2006·Journal of Substance Abuse Treatment·Thomas D'Aunno
Jul 20, 2005·Drug and Alcohol Dependence·Richard HallinanJohn Attia
Jul 13, 1999·Drug and Alcohol Dependence·C FelderC B Eap
Jun 1, 1994·Journal of the Royal Society of Health·P M Fleming, D Roberts
Aug 15, 2003·The Cochrane Database of Systematic Reviews·F FaggianoP Lemma

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Drug and Alcohol Dependence
E C StrainG E Bigelow
The International Journal of the Addictions
J R CaplehornD G Kleinbaum
© 2021 Meta ULC. All rights reserved